Teladoc (TDOC) Gains As Market Dips: What You Should Know
Teladoc (TDOC) reached $7.03 at the closing of the latest trading day, reflecting a +1.44% change compared to its last close.
Here's Why Investors Should Hold on to Teladoc Health Stock for Now
TDOC gains on Integrated Care growth, international expansion and cost cuts, but BetterHelp weakness and ongoing losses remain key challenges.
Teladoc (TDOC) Up 23.9% Since Last Earnings Report: Can It Continue?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
TDOC Q1 Earnings Miss, Revenues Down Y/Y on BetterHelp Weakness
Teladoc Health posts a y/y narrower Q1 loss and beats revenue estimates as international growth and cost cuts offset BetterHelp weakness and subscription declines.
Teladoc Health, Inc. (TDOC) Q1 2026 Earnings Call Transcript
Teladoc Health, Inc. (TDOC) Q1 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About Teladoc (TDOC) Q1 Earnings
While the top- and bottom-line numbers for Teladoc (TDOC) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Teladoc (TDOC) Reports Q1 Loss, Beats Revenue Estimates
Teladoc (TDOC) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.19 per share a year ago.
Unlocking Q1 Potential of Teladoc (TDOC): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Teladoc (TDOC) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading day saw Teladoc (TDOC) settling at $5.7, representing a -3.72% change from its previous close.
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note
Teladoc (TDOC) closed the most recent trading day at $5.69, moving 2.23% from the previous trading session.
Teladoc Health: Improving Fundamentals Support A Turnaround Story
Teladoc Health is transitioning from a cyclical D2C model to a higher-margin, data-driven B2B platform, supporting a Buy rating at low multiples. TDOC's BetterHelp segment is pivoting to insurance reimbursement, aiming for $75–90M in 2026 insurance revenue, reducing churn and acquisition costs. Integrated Care leverages PulseAI and proprietary datasets to deliver predictive, high-ROI services to employers and health plans, supporting premium pricing and margin expansion.
Why Teladoc Deserves Patience Now: Too Early to Buy, Too Risky to Sell
TDOC trades at a discount as Teladoc expands AI-driven care, cuts costs, and eyes better profitability, but BetterHelp weakness and rising competition cloud outlook.
